HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST).

Matthias EggerMamatha SauermannTom LoosliStefanie HossmannSelma RiedoNiko BeerenwinkelAntoine JaquetAlbert MingaJeremy RossJennifer GiandhariRoger D KouyosRichard Lessells

Published in: BMJ open (2024)

NCT06285110.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
hiv infected patients
human immunodeficiency virus
hiv aids
randomized controlled trial
hepatitis c virus
south africa
hiv testing